NANOG and embryonal carcinoma: In addition to rhabdomyosarcoma cell lines, we also examined established and patient-derived tumor cell lines of neurogenic origin, as well as the NTERA-2 human pluripotent embryonal carcinoma cell line, which served as a positive control of nuclear NANOG expression [39].